These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 9873176)

  • 1. Efficacy and safety of short-term itraconazole in tinea pedis: a double-blind, randomized, placebo-controlled trial.
    Svejgaard E; Avnstorp C; Wanscher B; Nilsson J; Heremans A
    Dermatology; 1998; 197(4):368-72. PubMed ID: 9873176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term itraconazole versus terbinafine in the treatment of tinea pedis or manus.
    Tausch I; Decroix J; Gwiezdzinski Z; Urbanowski S; Baran E; Ziarkiewicz M; Levy G; Del Palacio A
    Int J Dermatol; 1998 Feb; 37(2):140-2. PubMed ID: 9542675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy between two itraconazole generic products and the innovative itraconazole in the treatment of tinea pedis.
    Hoharitanon S; Chaichalotornkul J; Sindhupak W
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S167-72. PubMed ID: 16623023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole in the treatment of tinea pedis and tinea manuum: comparison of two treatment schedules.
    Schuller J; Remme JJ; Rampen FH; Van Neer FC
    Mycoses; 1998 Dec; 41(11-12):515-20. PubMed ID: 9919896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial.
    Savin RC; Zaias N
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):804-7. PubMed ID: 2229528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
    Wishart JM
    N Z Med J; 1994 Apr; 107(975):126-8. PubMed ID: 8145958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor.
    Hickman JG
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):785-7. PubMed ID: 8632075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tinea pedis with a single pulse of itraconazole.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2002; 12(2):157-9. PubMed ID: 11872413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis.
    Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B
    J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.
    Lachapelle JM; De Doncker P; Tennstedt D; Cauwenbergh G; Janssen PA
    Dermatology; 1992; 184(1):45-50. PubMed ID: 1313717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of 40% urea cream in the treatment of moccasin tinea pedis.
    Elewski BE; Haley HR; Robbins CM
    Cutis; 2004 May; 73(5):355-7. PubMed ID: 15186053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Econazole nitrate foam 1% for the treatment of tinea pedis: results from two double-blind, vehicle-controlled, phase 3 clinical trials.
    Elewski BE; Vlahovic TC
    J Drugs Dermatol; 2014 Jul; 13(7):803-8. PubMed ID: 25007362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. German randomized double-blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    Br J Dermatol; 1996 Jun; 134 Suppl 46():18-21: discussion 38. PubMed ID: 8763463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview.
    Doncker PD; Gupta AK; Marynissen G; Stoffels P; Heremans A
    J Am Acad Dermatol; 1997 Dec; 37(6):969-74. PubMed ID: 9418766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tinea pedis.
    Hay RJ; McGregor JM; Wuite J; Ryatt KS; Ziegler C; Clayton YM
    Br J Dermatol; 1995 Apr; 132(4):604-8. PubMed ID: 7748753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.